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Abstract: Aesthetic surgery is, in the USA at least, no longer a taboo subject. Outside North 
America, public acceptance continues to grow as more procedures are performed each year. While 
there appears, anecdotally, to be a decrease in patients undergoing cosmetic treatments because 
of the global financial crisis, the overall trend remains upward. Although popular television 
programs espouse the benefits of surgery, it is nonsurgical procedures that account, numerically, 
for the majority of procedures performed; in the USA, there was a 48% growth from 2000 to 
2008 in nonsurgical treatments undertaken by women, and 64% in men and while the average 
surgeon might perform 60 blepharoplasty operations in 2007, (s)he would also undertake 375 
botulinum injections, and almost 200 filler injections of varying sorts. Clearly there is enthusiasm 
for nonsurgical treatments, and this trend appears to be rising. With this in mind, we present an 
overview of the commonest filler injection material, hyaluronic acid. We present the mechanism 
of action, the purported risks and benefits, and briefly discuss technique.
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Introduction
Soft tissue facial deformities and skin changes associated with aging are known to 
affect psychosocial interactions. Aesthetic medicine has changed its focus rapidly 
over the years as a better understanding of the process of facial aging has affected 
the treatment approaches. Facial aging is now established to be due to a number of 
features. These include the involutional loss of dermis, resulting in loss of skin tone, 
gravitational changes due to loss of elasticity, remodeling of bony and cartilaginous 
structures, and sun damage causing photo-aging. More recently, the concept of 
volumetric loss in the face has further added to our understanding; fatty volume both 
migrates, and is lost from, the face. This occurs in predictable areas and a number 
of treatments now specifically address this issue either alone, or in combination with 
traditional rejuvenation techniques.
Some of these factors are preventable – most notably the sun damage to the skin 
that alters dermal composition – but others are less so; gravitational changes are 
dependent on the environment and volumetric loss is somewhat unavoidable and 
largely determined by genetic variables. The overall effect of these processes gives us 
the features of the aging face; flattening of the forehead, brow, glabella and temporal 
concavity in the upper face, descent of the nasal tip and flattening of the cheek in the 
mid face and recession of chin, appearance of jowls, loss of lip fullness, and descent 
of oral commissures in the lower face. In addition the aging process is manifested in 
the form of wrinkles throughout the face.Patient Preference and Adherence 2009:3 226
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Surgical procedures address laxity within the tissues 
and reposition the soft tissue of the face, on a ‘macro’ scale. 
Additional ‘micro’ adjustment can be made with fat transfer at 
the time of surgery, the so-called ‘volumetric’ facelift. Surgical 
fat transfer performed independently is still useful but does 
involve a hospital or clinic stay, and is quite clearly an invasive 
procedure. Importantly, however, surgical fat transfer, while 
elegant, does not address the finest lines in the face.
Wrinkles caused by active muscle contraction can be 
ameliorated by the use of botulinum toxin. For established 
lines there is anecdotal evidence that repeated use of 
this modality may allow the reversal of superficial lines, 
although formalized studies into this are limited. There is 
also a trend amongst the younger population to undergo 
botulinum treatments in order to prevent the formation of 
wrinkles, particularly in the forehead area. That said, most 
treatments for established wrinkles are aimed at volumetric 
replacement of soft tissue: dermal and/or deep tissue plane 
augmentation.
The ideal filler substance should be nonallergenic, non-
carcinogenic, with minimal adverse sequelae, no associated 
migration and minimal inflammatory response. It should be 
reproducible, durable, simple and painless to administer, with 
minimal recovery time, user-friendly, easily stored and large 
amounts should be readily available. It should preferably 
have a long-lasting effect with slow degradation in the body. 
There are advantages to temporary (rather than permanent) 
fillers; if the result is not to the patients liking, then it will 
be reversed over a period of time. Permanent fillers, while 
an attractive proposition, have two obvious drawbacks; 
misplacement of filler usually necessitates surgical removal, 
and the filler placement cannot subsequently be adjusted to 
account for ongoing age-related changes in the face.
History of soft tissue augmentation
The first surgical soft tissue augmentation agent used was 
autologous fat transplantation done by Neuber in 1893.1 
Paraffin was then tried but was seen to be associated with 
severe granuloma formation. Subsequently pure silicone was 
tried but this resulted in severe facial distortion with time. 
The popular use of dermal bulking agents however, started 
with the use of injectable bovine collagen in the early 1980s. 
As a small percentage of patients demonstrated allergy to this 
product, test injections were necessary, up to three weeks in 
advance of the actual procedure. More recent alternatives 
include acellular human dermis (Dermalogen®) and cultured 
fibroblasts (Isologen®); these were associated with less 
immunological intolerance and longer duration of action.
The history of medicine and, particularly aesthetics, is 
littered with ill-conceived ideas and treatments that might, 
at best, be described as ‘experimental’, poorly researched, 
and launched on an unsuspecting public with variable 
results. Most historical treatments have survived the test 
of time and therefore persist, with studies into efficacy 
retrospective rather than prospective. Unusually within this 
field, hyaluronic acid is a molecule that has been thoroughly 
researched and developed, initially for use in ophthalmic 
surgery, and then unsuccessfully trialed in orthopedic 
surgery, it came to the attention of plastic surgeons through 
the scientific field of tissue engineering. Within this latter 
field it was extensively researched with a view to producing 
a number of materials, in particular, dermal regeneration 
templates for use in reconstructive surgery (Figure 1). There 
are a number of formal research programs dedicated to the 
material, with significant international collaboration.
Biology of hyaluronic acid
Chemically, hyaluronic acid (Hyaluronan; HA) is a linear 
polymer of dimeric N-acetyl glucosamine and glucuronic 
acid (Figure 2) in huge macromolecular chains.2,3 The 
biology (mainly with regard to tissue engineering) has been 
extensively reviewed by the senior author3 but, for summary 
purposes, a resume is given here.
Hyaluronic acid is naturally present in the skin as part 
of the extracellular matrix and as a component of collagen. 
Its chemical structure is extremely well preserved across a 
number of species from Ascaris slime to mammals, making 
allergic reactions very rare. Due to its viscoelastic properties 
it acts as a ground substance of the dermis, and is also a 
component of joint fluid, vitreous of eye, disc nucleus, and 
the umbilical cord. It performs functions such as space 
Figure 1 Tissue engineering substrate made of hyaluronic acid.   water has been applied 
to one end of this sheet in order to demonstrate the solubility of the material.Patient Preference and Adherence 2009:3 227
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filling, lubrication, shock absorption, and also modulation of 
inflammatory cells and scavenging of free radicals.
Hyaluronic acid is extremely hydrophilic and biochemically 
retains water: hydrogen bonding occurs between adjacent 
carboxyl and N-acetyl groups to the extent that it retains up 
to 1000 times its weight in water. Sutherland and colleagues 
demonstrated that one gram of HA can bind up to 6 litres of 
water.4 In the skin, levels of HA naturally decrease with each 
passing year, resulting in dermal dehydration and rhytide for-
mation (wrinkles), a process accelerated by free radicals.
Hyaluronic acid was first isolated in bovine vitreous by 
Meyer and Palmer in 1934.5 Therapeutic use of various forms 
of hyaluronic acid started in ophthalmic surgery and later 
in orthopaedic surgery as a lubricant for joints, in patients 
with osteoarthritis.6 Native HA was noted to last only for a 
couple of days, but cross linking and chemically modifying 
(by esterification) the molecule fortified it against enzymatic 
degradation and improved its longevity and biocompatibility. 
Furthermore, the degree of esterification and cross-linking 
can be adjusted to alter the viscosity of the product, an impor-
tant feature that has served to expand the range of materials 
available for cosmetic use.
The duration of the cosmetic effect is determined 
primarily by enzymatic degradation by fibroblasts, resulting 
in the formation of shorter HA chains, which are then ingested 
by fibroblasts, macrophages and keratinocytes. From a tissue 
engineering perspective, these short-chain molecules have a 
number of specific wound healing properties in themselves, 
although this falls outwith the remit of this article.
Manufacture
Hyaluronic acid is identical in structure in all vertebrates but 
there are differences in protein and nucleic acid contaminants. 
There is no antigenic specificity for tissue or species and 
hence it has a low potential for allergic or immunogenic 
reactions. The various sources of HA include bacteria 
(Streptococcus zooepidemicus), rooster comb, human 
umbilical cord, and bovine vitreous humor. Adverse reaction 
to different preparations of HA has been established to be 
due to the cross linking process used rather than the source 
or nucleic acid contaminants, though the exact reason for 
the reactions is still unclear.7 The viscoelastic property of 
hyaluronic acid is determined by the length of the molecular 
chain, the concentration, the cross linking and the particle 
size. The differences in the various HA agents are decided 
by source derivation (animal vs. bacteria), cross linking (the 
method used to create cross linking and the degree of cross 
linking present), the concentration of HA, the amount of free 
HA (noncross-linked) and the particle size and uniformity 
of structure. Hence different manufacturing processes have 
different gel hardness and different amount of swelling 
caused by accumulation of water.
As a result of the (controlled) variability in manufacturing 
processes, a number of products are now commercially 
available. Generally, these are most easily conceived of with 
relation to the viscosity of the product and, therefore, the 
locations for which they would be indicated. For example, 
a viscous filler with a larger ‘granule’ size would not be 
suitable for injecting into the lips because of palpability 
(Figure 3). A softer product would not give the volume 
enhancement needed in deep tissue planes, etc. It is for this 
reason that the practitioner should have at hand a range of 
products so that bespoke treatment may be offered.
The primary indications for HA fillers are photo-aging 
wrinkles and in the nasolabial folds, lip rhytides, marionette 
lines, and volume enhancement such as lip filling and 
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Figure 2 The chemical composition of hyaluronic acid.   This diamer is polymerized into macromolecular chains which are then stabilized.Patient Preference and Adherence 2009:3 228
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Figure 3 (A) restylane SubQ®, a large-granule product, for deep dermal placement. (B) Juvederm Ultra 2®, a finer product for more superficial use. Note the difference in 
texture and the needles used for insertion; the former is placed using a cannula, whilst the latter is injected using a fine-gauge needle.
contouring, chin and cheek augmentation, and treatment of 
tear trough lines. Generally HA is not ideal for superficial 
wrinkles, instead it is more suited for deep folds and volume 
augmentation.8 But smaller molecular preparations have been 
shown to have good effect with superficial wrinkles. After a 
full pre-treatment assessment and pre-treatment photographs, 
the correct product should be selected. The greater the 
viscosity of the gel, the better the ability to resist shear and 
it can better exert a deformational force on surrounding 
tissue to correct a defect. The pay-off for such qualities is 
palpability and firmness to touch. The more superficial the 
injection, the higher the risk of visibility. This led to various 
HA products being used for different parts of the face due to 
difference in residence time, persistence, injectability, and 
need for local anesthetic.
Method for injection of hyaluronic acid
The procedure is generally carried out in the outpatient clinic 
setting, with the patient in an upright position for gravita-
tional wrinkles to be visible, with the head supported on a 
head rest to avoid sudden movements. Patients on aspirin or 
anticoagulants are advised to stop these beforehand. Anesthe-
sia, where applied, is usually in the form of topical anesthetic 
but field blocks or nerve blocks may be required especially 
for lip procedures which can otherwise be quite painful.
Using a 27–30 gauge needle, the agent is injected into 
the middle to deep dermis, except in lips where it is injected 
intramuscularly rather than intradermally. Larger molecular 
HA will require larger gauge needles for injection. If injected 
subcutaneously the material is wasted as its bioavailability 
is very short due to quicker enzymatic degradation and 
the effect may be limited. There are five commonly used 
techniques:
1.  Linear threading technique: the fold is filled by a single 
puncture to the epidermis and injecting the HA agent 
along the track of the needle producing linear volume. 
This is the commonest technique used by the senior 
author.
2.  Serial puncture technique: the fold is filled by multiple 
injections of the agent, all in a row.
3.  Fanning technique: here the epidermis is punctured once, 
and then the needle is fanned out while injecting the agent, 
producing volume in a triangular shape.
4.  Cross-hatching technique: this combines multiple injec-
tions of linear threading that crisscross at right angles to 
provide volume in a square shape. This is analogous to 
fat transfer techniques and is, in the author’s opinion, the 
best technique for deeper volumetric adjustment.
5.  Fern pattern technique: This involves serial puncturing 
in a linear manner but is done perpendicular to the actual 
fold on either side of it, increasing dermal stiffness.9
The senior authors’ current practice involves using a 
layering technique where heavier gels are injected into the 
deeper layers and lighter gels into the superficial layers. 
Constant movement of the needle is important in producing 
an even distribution of product, and avoiding injecting into 
a blood vessel. Injection just above the periosteum is very 
favorable as it produces re-inflation of the natural fat pads, 
in the brow, malar, buccal, and mental areas. After injec-
tion, the area should be massaged to smooth out any minor 
irregularities but care should be taken not to migrate the 
filler into an undesirable location. An ice pack may be used Patient Preference and Adherence 2009:3 229
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to decrease swelling and pain and the patient is advised 
to minimize movement of the injected area and avoid 
anticoagulants for the next couple of days to reduce incidence 
of bruising. Some physicians also advise abstinence from 
alcohol in the immediate post-procedure period, but evidence 
to support this is limited.
Combining HA filler treatment with injection of 
botulinum toxin is increasingly popular because it extends 
the cosmetic response of the HA agent and immobilizing 
the muscles increases the biodegradation time.10 However, 
research is limited on the subject of concommitant injection 
and the senior author prefers to separate botulinum and filler 
treatments by at least two weeks, performing the former first. 
Depending on the filler agent used and the depth at which it 
is injected, the effects last for 4–12 months.
It is difficult to be specific on anticipated duration of effect 
and patients should be advised of this. However, a few guide-
lines may be reasonably quoted. Most injections last at least 
three months and often up to six months, although there are 
anecdotal reports of longer duration and, indeed, some of the 
newer products claim up to 12 months efficacy. On balance, 
it is probably best to advise patients to expect 4–6 months 
efficacy, and that treatments may be needed 2–3 times per 
annum. Concommitant treatment with botulinum toxin may 
prolong these effects.11
There is some suggestion, although not proven as yet, that 
the repeated application of HA in the same area does, in fact, 
eventually provide a long-lasting result; whether this is due 
to the sustained increase of extracellular matrix, or whether 
this is the result of repeated scarring is not known.
However it is to be noted that intertreatment times are 
dependent upon patients representing; there is therefore 
a number of biases including patient perception of the 
effect, financial considerations, and the fact that this 
population are notoriously fickle. The senior author has 
a number of patients who claimed to be happy with their 
previous surgeon, but still chose to move to his practice 
for a variety of reasons unrelated to their previous 
practitioner.
Adverse reactions
Adverse reactions associated with HA fillers include 
bruising, edema, erythema, irregularities secondary to nodule 
formation, and delayed inflammatory reactions. These are seen 
in up to 12% of patients.12 The incidence of these reactions 
is much less frequent compared to injectable collagens and 
the volume of HA agent required is significantly less than 
that of collagen. Side effects such as sterile abscesses,13 
induction of sarcoid,14 and even angioedema15 have also 
been reported. Significant complications such as hematoma 
formation, significant swelling, etc are reported to occur in 
up to 1:1600 cases.13
Topical hyaluronic acid
Topical HA is not cross linked and is therefore easily 
absorbed. It was first used as a vehicle for the delivery of other 
drugs to the skin, particularly useful for sustained release 
and localized delivery and passes through the skin by active 
transport.9 As the significance of HA in water retention in 
the dermis has come to light, topical pure HA has become 
a cosmetic in its own right. In the superficial epidermis 
it acts as a humectant contributing to moisture content, and 
it decreases transepidermal water loss.16 Once absorbed 
into deeper dermis, it increases turgidity within the dermis. 
It also assists in proliferation of dermal fibroblasts, promoting 
extracellular matrix production in vitro,17 although there is 
no clear evidence this occurs in vivo. Since noncross-linked 
HA has a short half life, this will need frequent application, 
but as it may increase the water retention of the dermis, it is 
marketed as a plumping agent for the skin. The authors are 
not aware of any objective studies in this area and cannot 
comment upon the claims made.
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